These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29141305)

  • 1. [Research progress on rhinitis medicamentosa].
    Wang YN; Luan ZL; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):872-875. PubMed ID: 29141305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinitis medicamentosa.
    Ramey JT; Bailen E; Lockey RF
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal changes in rhinitis medicamentosa.
    Lin CY; Cheng PH; Fang SY
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):147-51. PubMed ID: 14994772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinitis medicamentosa. An experimental histopathological and histochemical study.
    Elwany SS; Stephanos WM
    ORL J Otorhinolaryngol Relat Spec; 1983; 45(4):187-94. PubMed ID: 6192384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?
    Casale M; Vella P; Moffa A; Sabatino L; Rinaldi V; Grimaldi V; Salvinelli F
    J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):55-62. PubMed ID: 29202563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
    Graf P
    Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].
    Yuta A; Ogawa Y
    Arerugi; 2013 Dec; 62(12):1623-30. PubMed ID: 24608651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P
    Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM; Barton BM; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):429-438. PubMed ID: 30325708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse.
    Caffier PP; Frieler K; Scherer H; Sedlmaier B; Göktas O
    Am J Rhinol; 2008; 22(4):433-9. PubMed ID: 18702912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after radio frequency ablation turbinate reduction (RFATR) among patients with rhinitis medicamentosa & withdrawal from decongestant topical spray abuse.
    Carmel Neiderman NN; Caspi I; Eisenberg N; Halevy N; Wengier A; Shpigel I; Ziv Baran T; Ringel B; Warshavsky A; Abergel A
    Am J Otolaryngol; 2023; 44(4):103842. PubMed ID: 36989755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Rhinitis Medicamentosa Successfully Treated with Rhinolight® Endonasal UV Phototherapy.
    Carson P; Lyons M
    Ir Med J; 2019 Feb; 112(2):874. PubMed ID: 30875167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinitis medicamentosa: aspects of pathophysiology and treatment.
    Graf P
    Allergy; 1997; 52(40 Suppl):28-34. PubMed ID: 9353558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa.
    Akpinar ME; Yigit O; Akakin D; Sarioz O; Ozkan N; Yildiz SD; Azizli E; Sehirli US
    Laryngoscope; 2012 Apr; 122(4):741-6. PubMed ID: 22374848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.